|
|
Blood, 1 March 2005, Vol. 105, No. 5, pp. 2124-2131.
Prepublished online as a Blood First Edition Paper on November 4, 2004; DOI 10.1182/blood-2004-07-2683.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Therapy-related acute myeloid leukemia–like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion
Jolanta Libura,
Diana J. Slater,
Carolyn A. Felix, and
Christine Richardson
From the Institute of Cancer Genetics, Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY; the Division of Oncology, Children's Hospital of Philadelphia, PA; and the Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia.
Rearrangements involving the MLL gene on chromosome band 11q23 are a hallmark of therapy-related acute myeloid leukemias following treatment with topoisomerase II poisons including etoposide. Therapy-related and de novo genomic translocation breakpoints cluster within a well-characterized 8.3-kb fragment of MLL. Repair of etoposide-stabilized DNA topoisomerase II covalent complexes may initiate MLL rearrangements observed in patients. We used a culture system of primary human hematopoietic CD34+ cells and inverse polymerase chain reaction to characterize the spectrum of stable genomic rearrangements promoted by etoposide exposure originating within an MLL translocation hotspot in therapy-related leukemia. Alterations to the region were observed at a readily detectable frequency in etoposide-treated cells. Illegitimate repair events after minimal repair included MLL tandem duplications and translocations, with minor populations of deletions or insertions. In stably repaired cells that proliferated for 10 to 14 days, the significant majority of illegitimate events were MLL tandem duplications, and several deletions, inversions, insertions, and translocations. Thus, etoposide promotes specific rearrangements of MLL consistent with the full spectrum of oncogenic events identified in leukemic samples. Although etoposide-initiated rearrangements are frequent, only a small subset of translocations occurs in cells that proliferate significantly.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
"You break it, you fix it"
- Peter D. Aplan
Blood 2005 105: 1843-1844.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
C. Bueno, P. Catalina, G. J. Melen, R. Montes, L. Sanchez, G. Ligero, J. L. Garcia-Perez, and P. Menendez
Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells
Carcinogenesis,
September 1, 2009;
30(9):
1628 - 1637.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. K. Slany
The molecular biology of mixed lineage leukemia
Haematologica,
July 1, 2009;
94(7):
984 - 993.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Wang, S. Carbajal, J. Vijg, J. DiGiovanni, and K. M. Vasquez
DNA Structure-induced Genomic Instability In Vivo
J Natl Cancer Inst,
December 17, 2008;
100(24):
1815 - 1817.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Harper and P. D. Aplan
Chromosomal Rearrangements Leading to MLL Gene Fusions: Clinical and Biological Aspects
Cancer Res.,
December 15, 2008;
68(24):
10024 - 10027.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Lichtman
Is There an Entity of Chemically Induced BCR-ABL-Positive Chronic Myelogenous Leukemia?
Oncologist,
June 1, 2008;
13(6):
645 - 654.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. van Waalwijk van Doorn-Khosrovani, J. Janssen, L. M. Maas, R. W.L. Godschalk, J. G. Nijhuis, and F. J. van Schooten
Dietary flavonoids induce MLL translocations in primary human CD34+ cells
Carcinogenesis,
August 1, 2007;
28(8):
1703 - 1709.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Dickerman
The Late Effects of Childhood Cancer Therapy
Pediatrics,
March 1, 2007;
119(3):
554 - 568.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. G. Moneypenny, J. Shao, Y. Song, and E. P. Gallagher
MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells
Carcinogenesis,
April 1, 2006;
27(4):
874 - 881.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
